Antiviral Therapy and Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence
- 27 February 2013
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 309 (8) , 765-767
Abstract
To the Editor: Nucleoside analogues are an effective treatment against HBV infection. However, previous studies have yielded inconclusive results regarding a reduction in the risk of HCC recurrence following the use of these treatments due to the small number of patients. Using a nationwide cohort, Dr Wu and colleagues1 reported survival benefits for patients treated with nucleoside analogues. We have 2 comments to make regarding their findings.Keywords
This publication has 3 references indexed in Scilit:
- Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver ResectionJAMA, 2012
- Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetesBMJ, 2010
- Immortal time bias in observational studies of drug effectsPharmacoepidemiology and Drug Safety, 2007